National and Kapodistrian University of Athens
Η συμβολή της ποζιτρονίκης υπολογιστικής τομογραφίας με 18-φθόριο-δεσοξυ-γλυκόζη, [18FDG-PET/CT) στη διαχείριση ασθενών με μυελοειδή καρκίνο του θυεροειδούς αδένα
Abstract
dc:descriptionAim: Serum calcitonin is an important tumor marker in the follow-up of patients with medullary thyroid carcinoma (MTC), and reliably reflects the presence of the disease. Aim of the study is the evaluation of the diagnostic accuracy of combined [18F]FDG-PET/CT in patients with MTC and elevated calcitonin levels. Another purpose of the study is to determine the likelihood of disease detection on [18F]FDG-PET/CT using various cut-off points for calcitonin levels. Materials-Methods: Between February 2007 and August 2012, 59 [18F]FDG-PET/CT scans were performed in 51 patients with MTC and elevated calcitonin levels for localization of recurrent disease. All patients underwent total thyroidectomy, as initial treatment. The group included 15 men and 36 women, 12-79 years old. Of these patients, 18 had hereditary MTC, 7 familial MTC and 11 as part of MEN IIA syndrome and 33 sporadic MTC. All patients underwent an additional examination with at least one other imaging method, during the last four weeks, but the results were negative or showed equivocal findings. Results: Among the 59 [18F]FDG-PET/CT, 29 were positive and 30 negative. The overall per-patient sensitivity of [18F]FDG-PET/CT was 44.1% in detecting MTC lesions in patients with increased serum calcitonin levels and either negative or equivocal conventional imaging. After division of the scans performed according to calcitonin levels, in cases with calcitonin level of up to 1000pg/ml we found a low sensitivity of 29.5% but in cases with calcitonin level >1000pg/ml, sensitivity was as high as 86.7%. An interesting finding of the study was that the overall sensitivity of [18F]FDG-PET/CT was lower (23%) in patients with MEN IIA syndrome. When we excluded these MEN IIA cases, then the overall per patient sensitivity of [18F]FDG-PET/CT increased to 50% and in cases with calcitonin levels >1000pg/ml increased to 100%. Conclusion: The findings of this report show that [18F]FDG-PET/CT is valuable for the detection of recurrence in patients with highly elevated calcitonin levels, >1000pg/ml, but in patients with lower calcitonin levels its contribution is questionable. Also, there is evidence that the sensitivity of [18F]FDG-PET/CT is lower in patients with MTC as part of MEN IIA syndrome.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Skoura, Evangelia
- Σκούρα, Ευαγγελία
Subjects
dc:subject × 14- Προζιτρονική υπολογιστική τομογραφία
- 18-φθόριο-δεσοξυ-γλυκόζη
- Μυελοειδής καρκίνος
- Καλσιτονίνη
- Καρκίνος θυρεοειδούς αδένα
- Positron computed tomography
- 18-fluoro-deoxy-glucose
- Medullary cancer
- Thyroid cancer
- Calcitonin
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40916